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ABSTRACT
Digital Adherence Technologies (DATs) are an increasingly popular
method for verifying patient adherence to many medications. We
analyze data from one city served by 99DOTS, a phone-call-based
DAT deployed for Tuberculosis (TB) treatment in India where nearly
3 million people are afflicted with the disease each year. The data
contains nearly 17,000 patients and 2.1M dose records. We lay the
groundwork for learning from this real-world data, including a
method for avoiding the effects of unobserved interventions in
training data used for machine learning. We then construct a deep
learning model, demonstrate its interpretability, and show how it
can be adapted and trained in different clinical scenarios to better
target and improve patient care. In the real-time risk prediction
setting our model could be used to proactively intervene with 21%
more patients and before 76% more missed doses than current
heuristic baselines. For outcome prediction, our model performs
40% better than baseline methods, allowing cities to target more
resources to clinics with a heavier burden of patients at risk of
failure. Finally, we present a case study demonstrating how our
model can be trained in an end-to-end decision focused learning
setting to achieve 15% better solution quality in an example decision
problem faced by health workers.
KEYWORDS
tuberculosis, treatment adherence, predictivemodeling, interpretabil-
ity, digital adherence technology, machine learning
1 INTRODUCTION
The World Health Organization (WHO) reports that tuberculosis
(TB) is among the top ten causes of death worldwide [25], yet in
most cases it is a curable and preventable disease. The prevalence of
TB is caused in part by non-adherence to medication, resulting in
greater risk of death, reinfection and contraction of drug-resistant
TB [38]. To combat non-adherence, the WHO recommends directly
Figure 1: 99DOTS electronic adherence dashboard seen by
health workers for a given month. Missed doses are marked
in red while consumed doses are marked in green.
observed treatment (DOT), in which a health worker directly ob-
serves and confirms that a patient is consuming the required med-
ication daily. However, requiring patients to travel to the DOT
facility causes financial burden, and potentially social stigma due
to public fear of the disease. Such barriers contribute to patients be-
ing lost to follow up, making TB eradication difficult. Thus, digital
adherence technologies (DATs), which give patients flexible means
to prove adherence, have gained global popularity [36].
DATs allow patients to be "observed" consuming their medica-
tion electronically, e.g. via two-way text messaging, video capture,
electronic pillboxes, or toll-free phone calls. Health workers can
then view real-time patient adherence on a dashboard such as Fig-
ure 1. In addition to improving patient flexibility and privacy, the
dashboard enables health workers to triage patients and focus their
limited resources on the highest risk patients. Preliminary studies
suggest that DATs can improve adherence in multiple disease set-
tings [6, 13, 33], prompting its use and evaluation for managing TB
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adherence [12, 20]. The WHO has even published a guide for the
proper implementation of the technology in TB care [26].
In this paper, we study how the wealth of longitudinal data pro-
duced by DATs can be used to help health workers better triage TB
patients and deliver interventions to boost overall adherence of their
patient cohort.The datawe analyze is fromMumbai, India and comes
from a partnership with the City TB Office of Mumbai; they have
implemented a DAT by which patients prove adherence through
daily toll-free calls. The DAT system was implemented with techni-
cal support from the healthcare technology company Everwell [11]
and is known as 99DOTS [7]. In fact, Everwell supports implemen-
tations of 99DOTS throughout India where there were an estimated
2.7 million cases of TB in 2017 [25]. In Mumbai, patients enrolled in
99DOTS currently receive interventions according to the following
general guidelines. If they have not taken their medication by the
afternoon, they (and their health worker) receive a text message
reminder. If the patient still does not take their medication by some
time later, the worker will call the patient directly. Finally, if a pa-
tient simply does not respond to these previous interventions after
some number of days, they may be personally visited by a health
worker. Note that many of these patients live in low-resource com-
munities where each health worker manages tens to hundreds of
patients; far more than they can possibly visit in a day. Thus, models
that can identify patients at risk of missing doses and prioritize
interventions by health workers are of paramount importance.
At first glance, the problem of predicting whom to target for
an intervention appears to be a simple supervised machine learn-
ing problem. Given data about a patient’s medication adherence
through their calls to the 99DOTS system, one can train a machine
learning model to predict whether they will miss medication doses
in the future. However, such a model ignores the concurrent inter-
ventions from health workers as the data was collected, and can
lead to incorrect prioritization decisions even when it is highly
accurate. For instance, we might observe that missed doses are
followed by a period of medication adherence: this does not mean
that people with missed doses are more likely to take medication,
but most likely that there was an intervention by a health worker
after which the patient restarted their medication.
Thus, for prescribing interventions, we need to disentangle the
effect of manual interventions from other underlying factors that
result in missing a dose. However, since this data was collected via
an extensive rollout to real patients, the data contains the effects
of interventions carried out by health workers. As an additional
challenge, health workers rarely record their interventions on the
99DOTS system, making it difficult to estimate their effects. While
there is a well-developed literature on estimating heterogeneous
treatment effects, standard techniques uniformly require knowledge
of which patients received an intervention [1, 8, 23, 37]. We note
that such gaps will be common as countries eagerly adapt DAT
systems in the hopes of benefiting low-income regions; to support
the delivery of improved care, we must be able to draw lessons
from this messy but plentiful data.
Therefore, we introduce a general approach for learning from
adherence data with unobserved interventions, based on domain
knowledge of the intervention heuristics applied by health workers.
We construct a proxy for interventions present in the historical
99DOTS data and develop a model to help prioritize targets of
interventions for health workers in different clinical scenarios:
Modeling Daily Non-Adherence Risk. We propose the pre-
diction task: given adherence data up to a certain time period for
patients not currently considered for intervention, predict risk of
non-adherence in the next week. We then introduce machine learn-
ing models for this task, which enable health workers to accurately
identify 21% more high-risk patients and catch nearly 76% more
missed doses compared to the heuristics currently used in practice.
Predicting success of treatment. Next, we apply our frame-
work to predict the final outcome at the end of the six-month
treatment for a patient based on their initial adherence data. Like
the previous model, this can be useful for health workers to pri-
oritize patients who are at risk of an unfavorable outcome, even
though their adherence might be high. Additionally, since this pre-
diction applies over the course of several months (rather than just
one week in the previous task), this model can be useful for public
health officials to better plan for TB treatment in their area, e.g. by
assigning or hiring additional health workers. We show that our
model can be used to achieve city-wide treatment outcome goals at
nearly 40% less cost than via baselines.
Detecting Low-Call Favorable Outcome Patients. One crit-
ical challenge of the 99DOTS system is that almost 15% of patients
regularly take their doses as prescribed, but choose not to call. This
causes the dashboard to falsely label those patients as HIGH risk,
putting extra strain on health workers to validate those patients’
adherence outside of 99DOTS. We uncover helpful insights includ-
ing a simple rule that could allow health workers to identify such
patients after only 7 days of adherence data has been collected,
allowing workers to transition those patients onto different adher-
ence monitoring technology.
Decision Focused learning. Finally, building on recent work
in end-to-end decision-focused learning [39], we build a machine
learning model which is tailored for a specific intervention plan-
ning problem. In the planning problem, workers must balance travel
costs while predicting which patients will benefit most from inter-
ventions. This example demonstrates how the modeling flexibility
enabled by our approach allows us to fine-tune and extract addi-
tional gains for particular decision support tasks (in this case, a 15%
improvement over our earlier model).
With our proposed models, 99DOTS can leverage years of ad-
herence data to better inform patient care and prioritize limited
intervention resources. Additionally, the challenges we address are
not unique to 99DOTS or TB adherence. DATs have been imple-
mented for disease treatment regimens such as HIV and diabetes
across the globe, and in each case health workers face the same
challenge of prioritizing patient interventions. By enabling health
workers to intervene before more missed doses, our model will
directly contribute to saving the lives of those afflicted with TB and
other diseases. That is why, though our model is not yet deployed,
we are excited about our continued collaboration with the City TB
Office of Mumbai and prospectively testing our model in the field.
2 RELATEDWORK
Outcomes and adherence research are well studied in the medical
literature for a variety of diseases [16]. Traditionally, studies have
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attempted to identify demographic or behavioral factors correlated
with non-adherence so that health workers can focus interventions
on patients who are likely to fail. Tuberculosis in particular, given
its lethality and prevalence in developing countries, has been stud-
ied throughout the world including in Ethiopia [35], Estonia [18],
and India [32]. Typically these studies gather demographic andmed-
ical statistics on a cohort, observe their adherence and outcomes
throughout the trial, then retrospectively apply survival [18, 35] or
logistic regression [32] analysis to determine covariates predictive
of failure. Newer work has improved classification accuracy via ma-
chine learning techniques such as Decision Trees, Neural Networks,
Support Vector Machines and more [14, 15, 22, 34]. However, the
conclusions connecting predictors to risk are largely the same as in
previous medical literature. While such studies have improved pa-
tient screening at the time of diagnosis, they offer little knowledge
about how risk changes during treatment. In this work, we show
how a patient’s real-time adherence data can be used to track and
predict risk changes throughout the course of their treatment. Pre-
vious studies likely did not address this question because accurately
measuring patient adherence has historically been difficult.
However, in recent years, new technologies have made measur-
ing daily adherence feasible in the context of many diseases such as
HIV or stroke. One such common device is an electronic pill bottle
cap that records the date/time when the cap is removed.While some
previous work has used electronic cap data to determine predic-
tors of non-adherence [5, 28, 29], almost no research has used the
daily measurements made possible by the electronic cap to study
changes in adherence over time. One study used the smart pillbox
data to retrospectively categorize patient adherence [17], but our
focus is on prospective identification of patients at risk of missing
doses before failures occur. As such devices enter mainstream use,
machine learning techniques like the ones we propose will play an
important role in the treatment of a wide spectrum of diseases.
Methodologically, our work is related to the large body of re-
search that deals with estimating the causal impact of interventions
from observational data [1, 8, 23, 37]. Given appropriate assump-
tions, such techniques allow for valid inferences about counterfac-
tual outcomes under a different policy for determining interven-
tions. However, they crucially require exact knowledge of when
interventions were carried out. This information is entirely absent
in our setting, requiring us to develop new methods for handling
unobserved interventions in the training data.
3 DATA DESCRIPTION
99DOTS provides each patient with a cover for every sleeve of
pills that associates a hidden unpredictable phone number with
each daily dose (note that one dose may consist of 2-5 pills). As
patients expose pills associated with each dose, they expose one
phone number per day. Each patient is instructed to place a toll-
free call to the indicated number each day. 99DOTS counts a dose
only if the patient calls the correct number for a given day. Due
to the sensitivity of the health domain, all data provided by our
partners was fully anonymized before we received it. The dataset
contains over 2.1 million dose records for about 17,000 patients,
served by 252 health centers across Mumbai from Feb 2017 to Sept
2018. Table 1 summarizes the data. We now describe the available
information in more detail.
Table 1: Data Summary. *Doses per patient was calculated
only on patients enrolled at least 6 months before Sept 2018.
Metric Count
Total doses recorded 2,169,976
—By patient call 1,459,908
—Manual (entered by health worker) 710,068
Registered phones 38,000
Patients 16,975
Health centers 252
Doses recorded per patient*
—Quartiles 57/149/188
—Min/Mean/Max 1/136/1409
Active patients per center per month
—Quartiles 7/18/35
—Min/Mean/Max 1/25/226
Patient Details. This is the primary record for patients who
have enrolled with 99DOTS. The table includes demographic fea-
tures such as weight-band, age-band, gender and treatment center
ID. Also included are treatment start and end dates, whether treat-
ment is completed or ongoing, and an "adherence string" which
summarizes a patient’s daily adherence. For patients who completed
treatment, a treatment outcome is also assigned according to the
standard WHO definitions [24, p. 5]. We label "Cured" and "Treat-
ment Complete" to be favorable outcomes and "Died", "Treatment
failed", and "Lost to follow-up" to be unfavorable outcomes.
Mapping phone numbers to patients. Patients must call
from a registered phone number for a dose to be counted by the
99DOTS system. Patients can register multiple phones, each of
which will be noted in the Phone Map table. We filtered out phones
that were registered to multiple patients since they could not be
uniquely mapped to patients. Also, patients who had any calls from
shared phones were filtered out to avoid analyzing incomplete call
records. This removed <1% of the patients from the data set.
Call Log. The Call Log records every call received by 99DOTS,
including from patients outside of Mumbai. It also includes "manual
doses" marked by health workers. Manual doses allow workers to
retroactively update a patient’s adherence on the dashboard. For
instance, if a patient missed a week of calls due to a cellular outage,
the worker could update the record to account for those missed
doses. We filtered the Call Log to only contain entries with patients
and phones registered in Mumbai, then attached a Patient ID to
each call by joining the filtered Call Log and Phone Map.
Patient Log. Each time a health worker interacts with a pa-
tient’s data in the 99DOTS dashboard, an automatic note is gen-
erated describing the interaction. The Patient Log records each
such event, noting the type of action, Patient ID, health worker
ID, the health worker’s medical unit, what action was taken, and
a timestamp. We did not calculate features from this table as they
tended to be sparse. However, this table was used for calculating
our training labels as described in Section 4.
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4 UNOBSERVED INTERVENTIONS
The TB treatment system operates under tight resource limitations,
e.g. one health worker may be responsible for more than 100 pa-
tients. Thus, it is critical that workers be able to accurately rank
patient risk and prioritize interventions accordingly. Machine learn-
ing can be used to accomplish such risk ranking with promising
accuracy, but it requires taking special care to understand how
intervention resources were allocated in the existing data.
Therefore, a key challenge is that users of the 99DOTS platform
generally do not record interventions: workers may make texts,
calls, or personal visits to patients to try to improve adherence,
but these interventions are not routinely logged in the data. While
far from ideal, such gaps are inevitable as countries with differing
standards of reporting adopt DATs for TB treatment. Given the
abundance of data created by DATs and their potential to impact
human lives, we emphasize the importance of learning lessons in
this challenging setting where unobserved interventions occur. We
next resolve this challenge by formulating a screening procedure
which identifies patients who were likely candidates for particular
interventions. However, we first illustrate the pitfalls of training and
using a risk model in this domain without our screening procedure.
Consider a naive model trained on the data as-is. Some of the
data will be influenced by the historical interventions carried out
by health workers. Thus, such a model will learn how to predict
patient adherence given existing worker behaviors. Now consider the
model’s intended use, namely to recommend a new prioritization of
limited resources based on risk. Then in deployment, some patients
who would have received interventions under the historical policy
would be judged not to require intervention by the new model.
While such prioritization is desirable under resource constraints,
naivemodels which ignore the impact of interventions in the dataset
can actually worsen patient outcomes. For instance, assume we
use the naive model to make a prediction about the patient from
Section 1 who had a week of missed doses, an intervention, then
a week of good adherence. By correctly predicting this patient’s
good adherence the naive model would recommend no intervention
– but this patient’s good adherence is contingent on the hidden
intervention in the data. Hence, the naive model will take resources
away from exactly the patients who would benefit most. To avoid
such pitfalls arising from unobserved interventions, we must train
and evaluate on data that is not influenced by such intervention
effects. We now describe our general method for reshaping data
around intervention effects to build valid models.
Intervention Proxy. Our goal is to use the available data to for-
mulate a proxy for when an intervention is likely to have occurred,
so that we can train our models on data points which are unaffected
by interventions. The key is to identify a conservative estimate for
where interventions occur to ensure that data with intervention sig-
nals are not included. First, we draw a distinction between different
types of health worker interventions. Specifically, we consider a
house visit to be a "resource-limited" intervention since workers
cannot visit all of their patients in a timely manner. Generally, this
is a last resort for health workers when patients will not respond to
other methods. Alternatively, we consider calls and texts to be "non-
resource-limited" interventions since they could feasibly be made
on a large number of patients at very low cost. Note that the naive
model in the previous section could make valid recommendations
for actions in addition to normal health worker behaviors. For this
reason, we develop a proxy only for resource-limited interventions
since non-resource-limited interventions come virtually for "free".
To formulate our proxy, we first searched for health worker
guidelines for carrying out house visits. The 2005 guide by India’s
Revised National Tuberculosis Control Program (RNTCP) [31] re-
quired that workers deliver a house visit after a single missed dose,
but updated guides are far more vague on the subject. Both the
most recent guide by the WHO [26] and by the RNTCP [30] leave
house visits up to the discretion of the health worker. However,
through discussions in Mumbai we learned that health workers
prioritize non-adherent patients for resource-limited interventions
such as house visits. Thus, we formulated our proxy based on the
adherence dashboard seen by health workers.
The 99DOTS dashboard gives a daily "Attention Required" value
for each patient. First, if a patient has an entry in the Patient Log
(i.e. provider made a note about the patient) in the last 7 days they
are automatically changed to "MEDIUM" attention, but this rule
affects <1% of the labels. The remaining 99% of labels are as follows:
If a patient misses 0 or 1 doses in the last 7 days, they are changed
to "MEDIUM" attention, whereas if they miss 4 or more they are
changed to "HIGH" attention. Patients with 2-3 missed doses retain
their attention level from the previous day. As our conservative
proxy, we assumed that only "HIGH" attention patients were candi-
dates for resource-limited interventions since the attention level is
a health worker’s primary summary of recent patient adherence.
This "Attention Required" system for screening resource-limited
interventions is generalizable to any daily adherence setting; one
need only to identify the threshold for a change to HIGH attention.
With this screening system, we can identify sequences of days
during which a patient was a candidate for a resource-limited in-
tervention, and subsequently avoid using signal from those days in
our training task. We accomplish this with our formulation of the
real-time risk prediction task as follows.
Consider a given set of patients on the dashboard of a health
worker at day t . Each patient will have an "Attention Required"
value in {MEDIUM, HIGH} representing their risk for that day.
Over the course of the next week up to t + 7, we will observe call
behavior for each patient and so the attention for each patient may
also change each day. Between t + 1 and t + 7, any patient that is at
HIGH on a given day may receive a resource-limited intervention
while those at MEDIUMmay not. Note that a change fromMEDIUM
to HIGH on day ti where t + 1 ≤ ti ≤ t + 7 means that a patient
missed 4 doses over days [ti − 6, ti ]. Patients at HIGH attention are
already known to the health worker, so the goal for our ML system
is to help prevent transitions from MEDIUM to HIGH by predicting
which patients are at greatest risk before the transition occurs and
allowing a health worker to intervene early.
We formalize our prediction task as follows. For each patient who
is MEDIUM at time t , use data from days [t−6, t] to predict whether
or not they change to HIGH at any time ti where t + 1 ≤ ti ≤ t + 7.
We now demonstrate that, with our intervention proxy, resource-
limited intervention effects cannot effect labels in this formulation.
First, if a patient stays at MEDIUM for all ti , then the label is 0.
Since the patient was at MEDIUM for all ti , our proxy states that
no resource-limited intervention took place between our prediction
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time t and the time that produced the label, t + 7. Second, if a
patient changes from MEDIUM to HIGH on day ti , then on day ti
we establish that the label is 1. By our proxy, any resource-limited
intervention effect must happen in [ti + 1, t + 7], since attention
is established at the end of a day ti . So again, we have that no
resource-limited intervention took place between our prediction
time t and the time that produced the label, ti .
Since we ensure that no resource-limited interventions happen
between our prediction time and the time the label is generated,
we ensure that intervention effects cannot influence our labels.
Now, if we predict that a patient will have good adherence we can
safely recommend no intervention since our combined screening
and training method guarantees that their good adherence is not
contingent on an intervention. Thus our classifier is suited to make
predictions that prioritize resource-limited interventions.
Despite messy data affected by unobserved interventions, this con-
servative, general proxy generates clean data without interventions.
In the next section, we show how this approach leads to significant
improvements in prediction performance and creates valid recom-
mendations to enable interventions among patients at immediate
risk of becoming non-adherent.
5 REAL-TIME RISK PREDICTION
We now build a model for the prediction task formalized in Section
4 which leverages our intervention screening proxy. Our goal was
to develop a model corresponding to the health worker’s daily task
of using their patients’ recent call history to evaluate adherence
risk with the goal of scheduling different types of interventions.
Better predictions allowworkers to proactively intervene withmore
patients before they miss critical doses.
Sample Generation. We started with the full population of
16,975 patients and generated training samples from each patient
as follows. We considered all consecutive sequences of 14 days
of call data where the first 7 days of each sequence were non-
overlapping. We excluded each patient’s first 7 days and the last
day of treatment to avoid bias resulting from contact with health
workers when starting or finishing treatment. We then took two
filtering steps. First, we removed samples where the patient had
more than 2 doses manually marked by a provider during the input
sequence since these patients likely had contact with their provider
outside of the 99DOTS system. Second, we removed samples in
which the patient did not miss any doses in the input sequence.
These samples made up the majority of data but included almost
no positive (HIGH risk) labels, which distorted training. Further,
positive predictions on patients who missed 0 doses are unlikely
to be useful; no resource-limited intervention can be deployed so
widely that patients with perfect recent adherence are targeted.
The above procedure generated 16,015 samples (2,437 positive).
Features. Each sample contained a time-series of call data and
static features. The time series included two sequences of length
7 for each sample. First was a binary sequence of call data (1 for a
call or manual dose and 0 for a miss.) The second sequence was a
cumulative total of all doses missed up to that day, considering the
patient’s full history in the program. The static features included
four demographic features from the Patient Table: weight-band, age-
band, gender, and treatment center ID. Additional features were
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ROC Curve - Weekly Risk Prediction
lw-Misses - auc:0.685
RF - auc:0.724
LEAP - auc:0.775
Figure 2: ROC Curve for the weekly risk prediction task
comparing the missed call baseline (blue), Random Forest
(yellow) and LEAP (green). Numbers under the blue curve
give thresholds used to calculate the baseline’s ROC curve.
engineered from the patient Call Logs and captured a patient’s
behavior rather than just their adherence. For example, does the
patient call at the same time every morning or sporadically each
day? This was captured through the mean and variance of the call
minute and hour. Other features included number of calls, number
of manual doses, mean/max/variance of calls per day as well as
days per call. We also included analogous features which used only
unique calls per day (i.e. calls to unique phone numbers), or ignored
manual doses. This process resulted in 29 descriptive features.
Models. We first tested standard models which use only the
static features: linear regression, a random forest [27] (with 100
trees and a max depth of 5), and a support vector machine. The
random forest performed best, so we exclude the others for clarity.
To leverage the time series data we also built a deep network, named
LEAP (Lstm rEal-time Adherence Predictor), implemented with
Keras [4] which takes both the time series and static features as
input. LEAP has two input layers: 1) a LSTM with 64 hidden units
for the time series input and 2) a dense layer with 100 units for the
static feature input.We concatenated the outputs of these two layers
to feed forward into another dense layer with 16 units, followed by
a single sigmoid activation unit. We used a batch size of 128 and
trained for 20 epochs.
Model Evaluation. To evaluate models we randomized all data
then separated 25% as the test set. We used 4-fold grid search to
determine the best model parameters. To deal with class imbalance,
we used SMOTE to over-sample the training set [3] implemented
with the Python library imblearn [19]. We also normalized features
as percentiles using SKLearn [27] which we found empirically to
work well. The baseline we compared against was the method used
by the existing 99DOTS platform to asses risk, namely doses missed
by the patient in the last week (lw-Misses).
Figure 2 shows the ROC curve of our models vs. the baseline.
The random forest narrowly outperforms the baseline and LEAP
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Table 2: LEAP vs. Baseline - Missed Doses Caught
Method True Positives Doses Caught
Baseline 204 204
LEAP 248 360
Improvement 21.6% 76.5%
LEAP vs. baseline for catching missed doses with a fixed
false positive rate. Our method learns behaviors indicative
of non-adherence far earlier than the baseline, allowing for
more missed doses to be prevented.
Table 3: LEAP vs. Baseline: Additional Interventions
TPR Baseline FPR LEAP FPR Improvement
75% 50% 35% 30%
80% 63% 41% 35%
90% 82% 61% 26%
LEAP vs. baseline for implementing new interventions. At
any TPR LEAP improves over the baseline FPR, allowing for
more precisely targeted interventions.
clearly outperforms both. However, to evaluate the usefulness of
our methods over the baseline, we consider how each method might
be used to plan house-visit interventions. Since this is a very limited
resource, we set the strictest baseline threshold to consider patients
for this intervention; that is 3 missed calls. Fixing the FPR of this
baseline method, Table 2 shows how many more patients in the
test set would be reached each week by our method (as a result of
its higher TPR) as well as the improvement in number of missed
doses caught. To calculate missed doses caught, we count only
missed doses that occur before the patient moves to HIGH risk.
Our model catches 21.6% more patients and 76.5% more missed doses,
demonstrating substantially more precise targeting than the baseline.
Table 3 shows that our model also outperforms the baseline
as both the true positive rate (TPR) and FPR increase, showcasing
our model’s greater discriminatory power. This is useful for non-
resource-limited interventions such as calls or texts. Recall, that our
screening procedure does not apply to this type of intervention, so
our predictions may only recommend additional interventions. It is
important that additional interventions be carefully targeted since
repeated contact with a given patient reduces the efficacy of each
over time [9]. This highlights the value of the greater precision
offered by our model, since simply blanketing the entire population
with calls and texts is likely counterproductive.
Interpretability. Our model has the potential to catch more
missed doses than current methods. However, these gains cannot
become reality without health workers on the ground delivering
interventions based on the predictions. Interpretability is thus a key
factor in our model’s usefulness because health workers need to
(a) SHAP values for LEAP’s dense layer features for a high-risk sample (≥0.5).
(b) SHAP values for LEAP’s LSTM layer input for 4 samples.
Figure 3: Visualization of the (a) dense layer and (b) LSTM
layer of our weekly risk prediction model. Red values cor-
respond to inputs that push predictions toward output of 1;
blue values push toward output of 0.
understand why our model makes its predictions to trust the model
and integrate its reasoning with their own professional knowledge.
However, the best predictive performance was achieved with
LEAP, a black-box network, rather than a natively interpretable
model like linear regression. Accordingly, we show how a visualiza-
tion tool can help users draw insights about our model’s reasoning.
We used the SHapley Additive exPlanations (SHAP) python library,
which generates visualizations for explaining machine learning
models [21]. Figure 3a shows how static features influence our
model’s prediction, where red features push predictions toward
1 (HIGH) and blue toward 0 (MEDIUM). Recall that features are
scaled as percentiles. In the blue, we see that this patient makes an
above-average number of calls each week pushing the prediction
toward 0. However, in the red we see that this patient has a very low
average but a high variability in time between calls. These features
capture that this patient missed two days of calls, then made three
calls on one day in an attempt to "back log" their previous missed
calls. Our model learned that this is a high-risk behavior.
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Figure 3b shows four different samples as input to the LSTM
layer of our model. The left shows the binary input sequence as
colored pixels where black is a call and yellow is a missed call. On
the right are SHAP values corresponding to each day of adherence
data, and grey denotes the start of the call sequence. We see that the
model learned that calls later in the week carry more weight than
calls earlier in the week. In Sample 1, the bottom two pixels (the
most recent calls) have blue SHAP values while the other pixels
have SHAP value close to 0. In Sample 3, a single missed call at the
beginning of the week combined with a call made at the end of the
week result in essentially cancelling SHAP values. Sample 4 also
has one missed call but on the last day of the week, resulting in a
net positive SHAP value.
This visualization technique provides intuitive insights about the
rules learned by our model. In deployment, workers could generate
these visualizations for any sample on the fly in order to aid their
decision-making process.
6 OUTCOME PREDICTION
Next we investigate how adherence data can be used to predict
final treatment outcome. Traditional TB treatment studies model
outcomes only as they relate to patient covariates such as demo-
graphic features. Exploiting daily real-time adherence data provided
by DATs, we investigate how using the first k days of a patient’s ad-
herence enables more accurate, personalized outcome predictions.
Note that intervention effects are still present in this formulation.
However, our screening procedure will not apply since we predict
over a period of several months, during which virtually all patients
would have had repeated in-person contact with health workers.
Sample Generation and Features. We formalize the predic-
tion task as follows: given the first k days of adherence data, predict
the final binary treatment outcome. We considered "Cured" and
"Treatment Complete" as favorable outcomes and "Died", "Lost to
follow-up", and "Treatment Failure" as unfavorable outcomes. We
only include patients who were assigned an outcome from these
categories. Further, since patients with the outcome "Died" or "Lost
to follow-up" exit the program before the full 6 months of treat-
ment, we removed those who were present for less than k + 1 days.
Finally, we removed patients who had more than half their first k
days marked as manual doses. This tended to improve prediction
performance which we conjecture is related to our observation
that practices for reporting manual doses varied by health center –
making the "meaning" of a manual dose ambiguous across samples
with respect to outcome. Our final dataset contained 4167 samples
with 433 unfavorable cases.
Through discussions in Mumbai, we learned that health workers
often build a sense of a patient’s risk of an unfavorable outcome
within their first month of treatment. To model this process, we
set k=35 for our prediction task, capturing the first month of each
patient’s adherence after enrollment in 99DOTS. (Note that this
is not a general rule for health workers, but simply served as a
motivation for our choice of k in this task.) Both the static features
and the sequence inputs were the same as calculated for the weekly
prediction task, but now taken over the initial 35 days. We included
two versions of the health worker baseline: missed doses in the last
week (lw-Misses) and total missed doses in 35 days (t-Misses).
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Figure 4: ROC curves for outcome prediction models.
Model Evaluation. We used the same models, grid search de-
sign, training process, and evaluation procedure as before. For the
Random Forest we used 150 trees and no max depth. For LEAP,
we used 64 hidden units for the LSTM input layer, 48 units for the
dense layer input, and 4 units in the penultimate dense layer.
Figure 4 shows ROC curves for eachmodel. Even the very simple
baseline of counting the calls made in the last 7 days before the
35 day cutoff is fairly predictive of outcome suggesting that the
daily data made available by DATs is valuable in evaluating which
patients will fail from TB treatment. Our ML models display even
greater predictive power, with LEAP performing the best, followed
closely by the random forest. We highlight how LEAP’s predictive
power could help officials minimize the costs necessary to reach
medical outcome goals for their city. For example, say Mumbai
launches a new initiative to catch 80% of unfavorable outcomes (true
positives in Figure 4) by hiring new health staff. Over the 17,000
patients in Mumbai, where 10% have unsuccessful outcomes as
in our test set, an 80% catch rate requires saving 1360 patients.
Using either baseline, achieving the 80% TPR requires a FPR of
70%, i.e., hiring additional staff to support 10710 total patients in
this example scenario. However, using LEAP only incurs a FPR
of 42%, translating to 6426 total patients. Recall that in Mumbai,
the average health worker cares for about 25 patients. At a yearly
starting salary of |216,864 [2] (or $3026) our model would yield
|37M in saved costs (or $525,000) per year.
7 DETECTING LOW-CALL FAVORABLE
OUTCOME PATIENTS
One additional critical challenge of the 99DOTS system is that some
patients regularly take their doses as prescribed, but choose not to
call. So according to the dashboard, they seem to be missing doses
and would be classified as HIGH risk by 99DOTS and by LEAP alike,
but in reality they should be MEDIUM risk. In fact, nearly 15% of
patients who had an outcome assigned as in section 3 called on less
than 25% of days of their treatment, but had a favorable outcome.
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We refer to these patients as low-call favorable outcome (LCFO).
We want to learn to identify these LCFO patients so that we do not
falsely rank them as HIGH risk despite the fact that they are not
calling. We also would like to be able to identify these patients early
on in treatment so that they may be reassigned to an adherence
monitoring method that better suits them.
Sample Generation and Features. We formulate this as a
binary prediction task as follows: given the first k days of adherence
data, predict whether or not the patient will both call on less than
25% of days from day k + 1 onward and have a favorable outcome.
We included only patients who were assigned an outcome as in
Section 3 and who had at least k + 7 days of adherence data. To
detect LCFO status as early as possible, we set k = 7. Thus our final
dataset contained 7265 patients, of which 1124 were positive. Note
that this population was larger than that of our outcome prediction
task because 1) patients were required to be in the program for less
time and 2) patients were not removed for having too many manual
doses since we found this to correlate with being LCFO.
Both the static features and the sequence inputs were the same as
calculated for the outcome prediction task, but this time taken over
the initial 7 days. We included the health worker baseline of missed
doses in the last week (lw-Misses), a random forest trained only on
demographic or "0-day" data (RF 0-day), a simple baseline which
counts the number of manual doses in the last week (lw-Manual), a
random forest trained on all non-sequence features over the initial
7 days (RF), and LEAP trained on all features and sequences.
Model Evaluation. We used the same models, grid search de-
sign, training process, and evaluation procedure as the previous
two formulations. For RF 0-day we used 300 trees and a max depth
of 10. For RF we used 200 trees and a max depth of 10. For LEAP,
we used 200 hidden units for the LSTM input layer, 1000 units for
the dense layer input, and 16 units in the penultimate dense layer.
Figure 5 shows ROC curves for each model. Interestingly, for
this task the lw-Misses baseline has almost no predictive power –
note that its ROC curve is essentially the line y = x . Conversely
notable is the performance of the lw-Manual heuristic which simply
counts the number of manual doses marked in the first 7 days for
each patient. This simple heuristic has almost equivalent predictive
power of our machine learning models. This is a valuable insight
for health workers which suggests that if the worker is already
manually marking doses for a patient early in their treatment, the
patient is likely to continue to be disengaged with the system in the
long term and should be considered for different adherence tech-
nology. The RF 0-day model has decent predictive power, though
closer inspection reveals that most of this power is encoded in the
treatment center ID – that is, LCFO patients tend to be concentrated
at certain treatment centers. This insight merits closer inspection
by supervisors about why patients in certain regions tend to be dis-
engaged with 99DOTS but still consuming pills. The RF and LEAP
models both perform slightly better than the lw-Manual baseline
but similarly to each other, suggesting that the adherence sequence
structure does not encode additional information for this predic-
tion task. These insights could improve processes by 1) helping to
identify hotspot regions of LCFO patients, after which supervisors
might investigate the underlying reason and adjust treatment ac-
cordingly at those centers and 2) the lw-Manual baseline, after only
7 days of dosage data, could give health workers a simple rule for
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Figure 5: ROC curves for LCFO prediction models.
identifying LCFO patients that should switch to different adherence
technology.
8 DECISION FOCUSED LEARNING
We now explore a case study of how our LEAP model can be spe-
cialized to provide decision support for a particular intervention.
We exploit end-to-end differentiability of the model to replace our
earlier loss function (binary cross-entropy) with a performance
metric tailored to the objective and constraints of specific deci-
sion problem. To accomplish this end-to-end training, we leverage
recent advances in decision-focused learning, which embeds an opti-
mization model in the loop of machine learning training [10, 39].
We focus on a specific optimization problem that models the
allocation of health workers to intervene with patients who are at
risk in the near future. This prospective intervention is enabled by
our real-time risk predictions and serves as an example of how our
system can enable proactive, targeted action by providers. However,
we emphasize that our system can be easily modified to capture
other intervention problems. Such flexibility is one benefit to our
technical approach, which allows the ML model to automatically
adapt to the problem specified by a domain expert.
Our optimization problem models a health worker who plans
a series of interventions over the course of a week. The health
worker is responsible for a population of patients across different
locations, and may visit one location each day. We use location
identifiers at the level of the TB Unit since this is the most gran-
ular identifier which is shared by the majority of patients in our
dataset. Visiting a location allows the health worker to intervene
with any of the patients at that location. The optimization problem
is to select a set of locations to visit which maximizes the number
of patients who receive an intervention on or before the first day
they would have missed a dose. We refer to this quantity as the num-
ber of successful interventions, which we choose as our objective
for two reasons. First, it measures the extent to which the health
worker can proactively engage with patients before adherence suf-
fers. Second, this objective only counts patients who start the week
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at MEDIUM attention and receive an intervention before they could
have transitioned to HIGH, dovetailing with our earlier discussion
on avoiding unobserved interventions in the data. This extends our
earlier intervention proxy to handle day-by-day rewards.
We now show how this optimization problem can be formalized
as a linear program.We have a set of locations i = 1...L and patients
j = 1...N where patient j has location ℓj . Over days of the week
t = 1...7, the objective coefficient c jt is 1 if an intervention on day
t with patient j is successful and 0 otherwise. Our decision variable
is xit , and takes the value 1 if the health worker visit location i on
day t and 0 otherwise. With this notation, the final LP is as follows:
max
x
7∑
t=1
L∑
i=1
xit
©­«
∑
j :ℓj=i
c jt
ª®¬
s.t.
L∑
i=1
xit ≤ 1, t = 1...7
7∑
t=1
xit ≤ 1, i = 1...L
0 ≤ xit ≤ 1 ∀i, t
where the second constraint prevents the objective from double-
counting multiple visit to a location. We remark that the feasible
region of the LP can be shown to be equivalent to a bipartite match-
ing polytope, implying that the optimal solution is always integral.
The machine learning task is to predict the values of the c jt ,
which are unknown at the start of the week. We compare three
models. First, we extend the lw-Misses baseline to this setting by
thresholding the number of doses patient j missed in the last week,
setting c jt = 0 for all t if this value falls below the threshold τ and
c jt = 1 otherwise. We used τ = 1 since it performed best. Second,
we trained our LEAP system directly on the true c jt as a binary
prediction task using cross-entropy loss. Third, we trained LEAP to
predict c jt using performance on the above optimization problem
as the loss function (training via the differentiable surrogate given
by [39]). We refer to this model as LEAP-Decision.
We created instances of the decision problem by randomly par-
titioning patients into groups of 100, modeling a health worker
under severe resource constraints (as they would benefit most from
such a system). We included all patients, including those with no
missed doses in the last week, since the overall resource allocation
problem over locations must still account for them.
Figure 6 shows results for this task. In the top row, we see that
LEAP and LEAP-Decision both outperform lw-Misses, as expected.
LEAP-Decision improves the number of successful interventions
by approximately 15% compared to LEAP, demonstrating the value
of tailoring the learned model to a given planning problem. LEAP-
Decision actually has worse AUC than either LEAP or lw-Misses, in-
dicating that typical measures of machine learning accuracy are not
a perfect proxy for utility in decision making. To investigate what
specifically distinguishes the predictions made by LEAP-Decision,
the bottom row of Figure 6 shows scatter plots of the predicted
utility at each location according to LEAP and LEAP-Decision ver-
sus the true values. Visually, LEAP-Decision appears better able
to distinguish the high-utility outliers which are most important
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Figure 6: Results for decision focused learning problem. Top
row: successful interventions and AUC for each method.
Bottom row: visualizations of model predictions.
to making good decisions. Quantitatively, LEAP-Decision’s predic-
tions have worse correlation with the ground truth overall (0.463,
versus 0.519 for LEAP), but better correlation on locations where
the true utility is strictly more than 1 (0.504 versus 0.409). Hence,
decision-focused training incentivizes the model to focus on mak-
ing accurate predictions specifically for locations that are likely
to be good candidates for an intervention. This demonstrates the
benefit of our flexible machine learning modeling approach, which
can use custom-defined loss functions to automatically adapt to
particular decision problems.
9 DISCUSSION
We present a framework for learning to make intervention recom-
mendations from data generated by DAT systems applied to TB care.
We develop a general approach for learning from medical adher-
ence data that contains unobserved interventions and leverage this
approach to build a model for predicting risk in multiple settings.
In the real-time adherence setting, we show that our model would
allow health workers to more accurately target interventions to
high risk patients sooner – catching 21% more patients and 76%
more missed doses than the current heuristic baseline. Next, we
train our model for outcome prediction, showing how adherence
data can more accurately detect patients at risk of unfavorable
treatment outcomes. We then derive insights that could help health
workers accurately identify LCFO patients with a simple rule after
just 7 days of treatment. We finally show that tailoring our LEAP
model for a specific intervention via decision-focused learning can
improve performance by a further 15%. The learning approaches
we present here are general and could be leveraged to study data
generated by DATs as applied to any medication regimen. With the
growing popularity of DAT systems for TB, HIV, Diabetes, Heart
Disease, and other medications, we hope to lay the groundwork for
improved patient outcomes in healthcare settings globally.
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